Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.

Sharma A, Lanuti M, He W, Palmer EL, Shepard JA, Digumarthy SR.

J Comput Assist Tomogr. 2013 Jan-Feb;37(1):9-14. doi: 10.1097/RCT.0b013e3182732341.

PMID:
23321827
[PubMed - indexed for MEDLINE]
2.

Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.

Okuma T, Okamura T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Koyama K, Inoue K, Nakamura K, Inoue Y.

Ann Nucl Med. 2006 Feb;20(2):115-21.

PMID:
16615420
[PubMed - indexed for MEDLINE]
3.

Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor.

Higaki F, Okumura Y, Sato S, Hiraki T, Gobara H, Mimura H, Akaki S, Tsuda T, Kanazawa S.

Ann Nucl Med. 2008 Apr;22(3):157-63. doi: 10.1007/s12149-007-0113-0. Epub 2008 May 23.

PMID:
18498029
[PubMed - indexed for MEDLINE]
4.

The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.

Alafate A, Shinya T, Okumura Y, Sato S, Hiraki T, Ishii H, Gobara H, Kato K, Fujiwara T, Miyoshi S, Kaji M, Kanazawa S.

Acta Med Okayama. 2013;67(2):105-12.

PMID:
23603927
[PubMed - indexed for MEDLINE]
Free Article
5.

Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?

Yoo DC, Dupuy DE, Hillman SL, Fernando HC, Rilling WS, Shepard JA, Siegel BA.

AJR Am J Roentgenol. 2011 Aug;197(2):334-40. doi: 10.2214/AJR.10.6108.

PMID:
21785078
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.

Bollineni VR, Widder J, Pruim J, Langendijk JA, Wiegman EM.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e551-5. doi: 10.1016/j.ijrobp.2012.01.012. Epub 2012 Mar 13.

PMID:
22417800
[PubMed - indexed for MEDLINE]
7.

Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.

Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.

Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.

PMID:
22999369
[PubMed - indexed for MEDLINE]
8.

CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.

Vahdat S, Oermann EK, Collins SP, Yu X, Abedalthagafi M, Debrito P, Suy S, Yousefi S, Gutierrez CJ, Chang T, Banovac F, Anderson ED, Esposito G, Collins BT.

J Hematol Oncol. 2010 Feb 4;3:6. doi: 10.1186/1756-8722-3-6.

PMID:
20132557
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.

Okuma T, Matsuoka T, Okamura T, Wada Y, Yamamoto A, Oyama Y, Koyama K, Nakamura K, Watanabe Y, Inoue Y.

J Nucl Med. 2006 Aug;47(8):1351-8.

PMID:
16883016
[PubMed - indexed for MEDLINE]
Free Article
10.

Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning.

Blokhuis TJ, van der Schaaf MC, van den Tol MP, Comans EF, Manoliu RA, van der Sijp JR.

Scand J Gastroenterol Suppl. 2004;(241):93-7.

PMID:
15696856
[PubMed - indexed for MEDLINE]
11.

Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT.

Suzawa N, Yamakado K, Takao M, Taguchi O, Yamada T, Takeda K.

Clin Nucl Med. 2013 Apr;38(4):e166-70. doi: 10.1097/RLU.0b013e31828166f6.

PMID:
23429399
[PubMed - indexed for MEDLINE]
12.

The usefulness of pre-radiofrequency ablation SUV(max) in 18F-FDG PET/CT to predict the risk of a local recurrence of malignant lung tumors after lung radiofrequency ablation.

Harada S, Sato S, Suzuki E, Okumura Y, Hiraki T, Gobara H, Mimura H, Kanazawa S, Kaji M, Fujiwara T.

Acta Med Okayama. 2011 Dec;65(6):395-402.

PMID:
22189480
[PubMed - indexed for MEDLINE]
Free Article
13.

Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.

Liao S, Penney BC, Wroblewski K, Zhang H, Simon CA, Kampalath R, Shih MC, Shimada N, Chen S, Salgia R, Appelbaum DE, Suzuki K, Chen CT, Pu Y.

Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):27-38. doi: 10.1007/s00259-011-1934-6. Epub 2011 Sep 23.

PMID:
21946983
[PubMed - indexed for MEDLINE]
14.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

PMID:
20197344
[PubMed - indexed for MEDLINE]
Free Article
15.

Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors.

Sharma A, Digumarthy SR, Kalra MK, Lanuti M, Shepard JA.

AJR Am J Roentgenol. 2010 May;194(5):1250-6. doi: 10.2214/AJR.09.3206.

PMID:
20410411
[PubMed - indexed for MEDLINE]
16.

FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.

Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H.

Clin Nucl Med. 2003 Mar;28(3):192-7.

PMID:
12592125
[PubMed - indexed for MEDLINE]
17.

Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET.

Obrzut S, Pham RH, Vera DR, Badran K, Hoha CK.

Nucl Med Commun. 2007 Jan;28(1):7-13.

PMID:
17159543
[PubMed - indexed for MEDLINE]
18.

Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).

Agarwal M, Brahmanday G, Bajaj SK, Ravikrishnan KP, Wong CY.

Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):691-8. doi: 10.1007/s00259-009-1291-x. Epub 2009 Nov 14.

PMID:
19915840
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.

Schoellnast H, Larson SM, Nehmeh SA, Carrasquillo JA, Thornton RH, Solomon SB.

Cardiovasc Intervent Radiol. 2011 Feb;34 Suppl 2:S182-5. doi: 10.1007/s00270-010-9898-7. Epub 2010 May 28.

PMID:
20508937
[PubMed - indexed for MEDLINE]
20.

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V.

J Clin Oncol. 2004 Aug 15;22(16):3255-60.

PMID:
15310769
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk